Debt-to-equity of Silk Road Medical Inc from 30 Sep 2019 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Silk Road Medical Inc quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Jun 2024.
  • Silk Road Medical Inc Debt-to-equity for the quarter ending 30 Jun 2024 was 73%, a 7.5% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Silk Road Medical Inc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 73% -5.9% -7.5% 30 Jun 2024
Q1 2024 72% -23% -24% 31 Mar 2024
Q4 2023 70% -42% -37% 31 Dec 2023
Q3 2023 67% -69% -51% 30 Sep 2023
Q2 2023 79% -34% -30% 30 Jun 2023
Q1 2023 95% +3.6% +3.9% 31 Mar 2023
Q4 2022 112% +31% +38% 31 Dec 2022
Q3 2022 137% +63% +85% 30 Sep 2022
Q2 2022 113% +48% +73% 30 Jun 2022
Q1 2022 91% +33% +57% 31 Mar 2022
Q4 2021 81% +19% +31% 31 Dec 2021
Q3 2021 74% +7.7% +12% 30 Sep 2021
Q2 2021 65% -8.3% -11% 30 Jun 2021
Q1 2021 58% -25% -30% 31 Mar 2021
Q4 2020 62% -303% -83% 31 Dec 2020
Q3 2020 66% +282% 30 Sep 2020
Q2 2020 73% 30 Jun 2020
Q1 2020 83% 31 Mar 2020
Q4 2019 365% 31 Dec 2019
Q3 2019 -216% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.